ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Adjunctive Corticosteroid Immunosuppression Improves Hyperbilirubinemia Following Liver Transplantation (OLT)

G. Malat, D. Reich, G. Xiao, M. Harhay, K. Ranganna, D. Lee, S. Guy, S. Munoz.

Drexel University, Philadelphia.

Meeting: 2018 American Transplant Congress

Abstract number: C213

Keywords: Graft function, Immunosuppression, Lung transplantation

Session Information

Date: Monday, June 4, 2018

Session Name: Poster Session C: Liver: Immunosuppression and Rejection

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall 4EF

Related Abstracts
  • The Efficacy of Low Dose Steroid Therapy for Postoperative Hyperbilirubinemia in Liver Transplant Recipients: A Prospective Randomized Controlled Trial
  • Adding Anti-Inflammatory Agents During Normothermic Ex-Vivo Liver Perfusion Improves the Preservation of Pig Liver Grafts Before Transplantation.

Background: Deceased donor orthotopic liver transplantation (OLT) can result in significant delayed function, manifesting as protracted hyperbilirubinemia, depending on the intensity of the ischemia/reperfusion injury (IRI). We recently changed our OLT protocol to include corticosteroid (CS) tapering post-transplant, as an anti-inflammatory agent against IRI.

Methods: We performed a retrospective cohort study of 208 OLTs performed at our center since 2002. We compared one-week post-OLT bilirubin levels between those that did and did not receive CS.

Results: The CS group consisted of 67 patients vs. 141 non-CS patients. Demographics were similar between the groups (table 1). Dosing of calcineurin inhibitors and antimetabolites was similar between the groups. One week median tacrolimus levels were slightly higher in the non-CS group vs. the CS group (7.0 ng/mL IQR (4.8-9.7) vs. 5.1 ng/mL IQR (3.0-7.8)). Median cold ischemia time (CIT) was shorter in the non-CS group vs. CS group (10 hours IQR (8.3-11.1) vs. 9.1 hours IQR (7.0-10.0), p = 0.02). Despite the shorter CIT, total bilirubin at 7 days post-OLT was increased in the non-CS group vs. the CS group (4.73 mg/dL IQR (2.1-11.2) vs. 2.21 mg/dL IQR (1.2-7.6), p = 0.001). Calculated MELD scores utilizing labs at one week were lower in the CS vs. non-CS group, likely related to the total bilirubin (non-CS = 15.2 vs. CS = 12.6, p = 0.02).

Conclusion: Our results suggest that the advantages of CS may extend beyond prevention of rejection. These findings should be confirmed in randomized studies to account for potential unmeasured confounders.

CS (n=67) Non-CS (n=141)
Deceased Donors Age > 60 27% 24%
Donation after Cardiac Death Donors 0% 4%
Donor BMI, median (IQR) 25.7 (22.4-29.9) 26.0 (23.2-30.3)
Gender, male 68% 80%
Recipient Age, median (IQR) 55 (51-63) 57 (50-60)
Recipient ethnicity, African American 21% 16%
Liver disease secondary to HCV 42% 61%
Tacrolimus based Immunosuppression 97% 98%

CITATION INFORMATION: Malat G., Reich D., Xiao G., Harhay M., Ranganna K., Lee D., Guy S., Munoz S. Adjunctive Corticosteroid Immunosuppression Improves Hyperbilirubinemia Following Liver Transplantation (OLT) Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Malat G, Reich D, Xiao G, Harhay M, Ranganna K, Lee D, Guy S, Munoz S. Adjunctive Corticosteroid Immunosuppression Improves Hyperbilirubinemia Following Liver Transplantation (OLT) [abstract]. https://atcmeetingabstracts.com/abstract/adjunctive-corticosteroid-immunosuppression-improves-hyperbilirubinemia-following-liver-transplantation-olt/. Accessed January 25, 2021.

« Back to 2018 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Left-Sided Donor Nephrectomy Predisposes Living Kidney Donors to Latent Adrenal Insufficiency with Symptoms of Fatigue and Inferior Quality of Life.
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.